This content is machine translated Moderate to severe plaque psoriasis High patient satisfaction thanks to rapid and sustained efficacy of ixekizumab From the patient’s point of view, a rapid onset of action is one of the most important treatment goals, along with appearance-free skin. Both the data from the UNCOVER-3 study…
View Post 3 min This content is machine translated Psoriasis Outlook on possible future therapy options As part of this year’s AAD, several speakers reported on on research-stage antipsoriatic agents, which showed promising results in phase 2 trials. Biologics and tyrosine kinase 2 inhibitors are among…
View Post 5 min This content is machine translated AAD 2018, San Diego From rare and common skin conditions Psoriasis therapy has been significantly expanded in recent years. New substances are continuously entering the market. Merkel cell carcinoma, on the other hand, is a rare skin tumor with a…
View Post 6 min This content is machine translated AAD Conference in Orlando Psoriasis – head-to-head comparison with clear winner Psoriasis therapy has made great progress in recent years. This is due on the one hand to immunological research into the pathogenesis and the recognition of the systemic nature of…
View Post 6 min This content is machine translated AAD Congress in Washington Vaccination against herpes and social impact of acne Data on therapeutic immunization for genital herpes were presented at the American Academy of Dermatology Congress in Washington. The effects on viral excretion are promising, but the compound has yet…
View Post 6 min This content is machine translated Congress of the American Academy of Dermatology Acne and atopic dermatitis – ways of therapy Two studies presented at the annual meeting of the American Academy of Dermatology in San Francisco were devoted to acne therapy. Both tested a fixed combination of adapalene and benzoyl…